References
- Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1 + 2, and plasmin-plasmin inhibitor complex. Circulation 1997;96:19–21.
- Haus E. Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention. Adv Drug Deliv Rev 2007;59:966–84.
- Scheer FA, Michelson AD, Frelinger AL, 3rd, Evoniuk H, Kelly EE, McCarthy M, Doamekpor LA, Barnard MR, Shea SA. The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors. PLoS One 2011;6:e24549.
- Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E, and the MILIS study group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315–22.
- Casetta I, Granieri E, Fallica E, la Cecilia O, Paolino E, Manfredini R. Patient demographic and clinical features and circadian variation in onset of ischemic stroke. Arch Neurol 2002;59:48–53.
- Decousus HA, Croze M, Levi FA, Jaubert JG, Perpoint BM, De Bonadona JF, Reinberg A, Queneau PM. Circadian changes in anticoagulant effect of heparin infused at a constant rate. BMJ (Clin Res Ed) 1985;290:341–4.
- Oswald E, Finsterwalder T, Innerhofer N, Haas T, Mittermayr M, Strohmaier S, Innerhofer P. Comparison of arterial versus venous parameters of rotational thromboelastometry and multiple platelet function analyzer: results of a pilot study. Scand J Clin Lab Invest 2013;73:538–45.
- Kruger JC, Meves SH, Kara K, Mugge A, Neubauer H. Monitoring ASA and P2Y12-specific platelet inhibition – comparison of conventional (single) and multiple electrode aggregometry. Scand J Clin Lab Invest 2014;74:568–74.
- Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Investigators RA. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365: 883–91.
- Eller T, Busse J, Dittrich M, Flieder T, Alban S, Knabbe C, Birschmann I. Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Clin Chem Lab Med 2014; 52:835–44.
- Timm A, Fahrenkrug J, Jorgensen HL, Sennels HP, Goetze JP. Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations. Eur J Haematol 2014;93:48–53.
- Siller-Matula JM, Gouya G, Wolzt M, Jilma B. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers. Thromb Haemost 2009;102:397–403.
- Wurtz M, Hvas AM, Christensen KH, Rubak P, Kristensen SD, Grove EL. Rapid evaluation of platelet function using the Multiplate® Analyzer. Platelets 2014;25:628–33.
- Zhang HZ, Yu LH, Kim MH. Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin. Platelets 2013;24:339–47.
- Spiel AO, Derhaschnig U, Schwameis M, Bartko J, Siller-Matula JM, Jilma B. Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial. Clin Sci (Lond) 2012;123:591–600.
- Hartley PS. The diurnal tick-tockery of platelet biology. Platelets 2012;23:157–60.
- Kozinski M, Bielis L, Wisniewska-Szmyt J, Boinska J, Stolarek W, Marciniak A, Kubica A, Grabczewska Z, Navarese EP, Andreotti F, Siller-Matula JM, Rosc D, Kubica J. Diurnal variation in platelet inhibition by clopidogrel. Platelets 2011;22:579–87.
- Dalby MC, Davidson SJ, Burman JF, Davies SW. Diurnal variation in platelet aggregation iwth the PFA-100 platelet function analyser. Platelets 2000;11:320–4.
- Spiel AO, Bartko J, Schwameis M, Firbas C, Siller-Matula J, Schuetz M, Weigl M, Jilma B. Increased platelet aggregation and in vivo platelet activation after granulocyte colony- stimulating factor administration. A randomised controlled trial. Thromb Haemost 2011;105:655–62.
- Karon BS, Tolan NV, Koch CD, Wockenfus AM, Miller RS, Lingineni RK, Pruthi RK, Chen D, Jaffe AS. Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. Clin Chem 2014;60:1524–31.
- Johnston LR, Larsen PD, La Flamme AC, Harding SA. Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate parameters of rotational thromboelastometry analyser. Platelets 2013;24:303–7.